Trial Profile
Combination Therapy of Tenofovir and Telbivudine in Immune-tolerant Patients With Chronic Hepatitis B Awaiting Assisted Reproduction
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary) ; Tenofovir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 30 Apr 2018 Status changed from active, no longer recruiting to completed.
- 14 May 2017 Status changed from recruiting to active, no longer recruiting.
- 29 Jul 2016 Planned number of patients changed from 90 to 120.